NASDAQ
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Open
$33.34
Previous Close
$32.84
Day High
$35.64
Day Low
$32.24
52 Week High
$36.53
52 Week Low
$5.49
No price data available for this timeframe.